Theseus Capital Partners
Swarmer's largest institutional shareholder per its SEC 424B4 cap table: 2,324,961 shares (22.0% pre-offering, 17.2% post-offering), held via Series A-1 preferred plus warrants. Its principal, Philip Wagenheim, sits on Swarmer's board. Not named in Swarmer's Series A press release — identified only via the SEC filing.
Investment vehicle of Philip Wagenheim (Managing Partner, Broadband Capital Partners, LLC; prior board and executive roles at Immunome, Zynerba Pharmaceuticals, ExamWorks, Vroom, and Montrose Environmental Group). No independent public thesis, team, or track record beyond its stake in Swarmer, Inc., which appears to be its only publicly known investment, held via Series A-1 preferred stock plus warrants with Wagenheim as sole managing member. Not to be confused with unrelated firms of similar name (Theseus Capital Ltd., Theseus Capital Management, Theseus Group LLC, Theseus Capital, Inc.).
Overview
- Firm
- Theseus Capital Partners, LLC
- Headquarters
- Founded
- 0
- AUM
- Stages
- Thesis
Portfolio companies1
Partners0
No linked records yet.
Sources & citations2
Each claim links to its underlying source. Confidence reflects how directly the source supports the claim.
- 1
Theseus Capital Partners, LLC holds 2,324,961 shares of Swarmer (22.0% before offering, 17.2% after), via Series A-1 preferred stock and warrants; its principal Philip Wagenheim is a Swarmer director
U.S. Securities and Exchange Commission (EDGAR): Swarmer, Inc. Form 424B4 — Principal StockholdersVerified2026-03-17 - 2
A March 2026 Schedule 13D discloses Theseus Capital Partners, LLC holding a 10.2% stake in Swarmer, Inc., with Philip Wagenheim as managing member exercising sole voting and dispositive power.
StockTitan: Swarmer director discloses 10.2% stake in 13DVerified2026-03-23